Skip to content

Effect of a Smartphone Application on Oral Contraceptive Adherence in College Females

Effect of a Smartphone Application on Oral Contraceptive Adherence in College Females: a Randomized-controlled Trial.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01947842
Enrollment
0
Registered
2013-09-23
Start date
2014-01-31
Completion date
2014-12-31
Last updated
2023-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence to Oral Contraceptive Therapy

Keywords

Smartphone, adherence, contraceptives, college, females

Brief summary

This research study is to see if smartphone applications help college women remember to take birth control better than pharmacist consultation alone. Patients will participate in this study for 6 (six) months. The study will have two groups. Patients will be randomly assigned to one group or the other. The control group will be counseled by the pharmacist on the importance of taking birth control as prescribed. The study group will get the same counseling, but will also be set up to receive reminders to take medication on a smartphone application called Dosecast.

Interventions

DEVICESmartphone App Dosecast

The Dosecast app is configured to remind the patient to take their medication.

Sponsors

Belmont University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* female gender * 18-29 years of age * current prescription for an OCP * currently enrolled as a student at the institution associated with the pharmacy * possession of a compatible smartphone.

Exclusion criteria

* Pregnant patients * Patients who become pregnant during the study will discontinue, but their data up until time of discontinuation will be used * Patients using other forms of contraception (patch, injection, IUD, intra-vaginal ring, implant).

Design outcomes

Primary

MeasureTime frameDescription
Doses Missed6 monthsNumber of doses of oral contraceptive missed over a six-month period.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026